Global Pharmaceutical Solutions,
Locally Trusted Expertise
WANBAOLUO Co., Ltd. is a subsidiary of Zhenlong (Hong Kong) Limited and its sole authorized entity to legally import and distribute AOLI medical products in over 80 countries across the world.
Vision and Mission
WANBAOLUO Co., Ltd. is a leading global biopharmaceutical company dedicatedto enhancing human life through the integration of science, technology, and talent. Proudly to introduce our AOLI tadalafil and dapoxetine hydrochloride tables, our vision is to improve the quality of life through innovative medical solutions.
50
PRODUCTS
80
4
20
COUNTRIES
POPULATION
USD REVENUE
Billion
——
——
——
General Information
of LianHuan
——
Million
China Main Bord Listed
Top 100 of China's Pharma companies
Lianhuan Pharma has formed two R&D platfor-ms in Nanjing and Yang-zhou based on acade-mician workstation and doctor workstation, and has established good technical cooperation rel-ations with Shanghai Institute of Pharmaceutical Research of Chinese Academy of Sciences and China Pharmaceutical University, etc.
R&D Resources
Jiangsu Lianhuan Pharmaceutical Co., Ltd. has grown into national high-tech enterprise integr-ating R&D,manufacturing and marketing, and its pr-oducts involveorganic intermediates, chemi-cal APIs and chemical finshe- d pharmaceutical dosage forms. The company's annual revenue exceeds RMB 2 billion.
Product Portfolio
The company's product portfolio encompa-sses five major therapeutic
categories:
1. Urological System 2. Antihistamines
3. Cardiovascular 4. Steroid Hormones
5. Antibiotic
Jiangsu Lianhuan Pharmaceutical Co., Ltd. was founded in December 1999.Successfully listed on the main board of Shanghai Stock Exchange in March 2003.The stock isreferred to as “Lianhuan Pharma” and the stock code is 600513.
Corporate Certifications
AOLI Products
AOLI Tadalafil 20mg
AOLI Dapoxetine Hydrochloride 30mg
The only FDA-approved PDE 5 inhibitor significantly improves erectile function and helps patients comp-lete sexual life.
The first on-demand oral medication approved for primary PE and secondary PE in many countries other than the United States.